Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Market Cap	46.50B
Revenue (ttm)	116.31B
Net Income (ttm)	7.51B
Shares Out	5.00M
EPS (ttm)	1,501.10
PE Ratio	6.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,800
Average Volume	3,217
Open	9,400.00
Previous Close	10,400.00
Day's Range	9,400.00 - 9,400.00
52-Week Range	8,100.00 - 10,600.00
Beta	0.65
RSI	47.99
Earnings Date	Jul 18, 2025

About HNX:MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina. The company offers veterinary medicine, aquatic medicine, and animal nutrition. It provides products for cattle, pig, chicken, duck, dog, cat, fish, and other species through distributors and agents. The company was formerly known as Cai Lay Livestock and Veterinary Pharmacy Company and changed its name to Cai Lay Veterinary Pharmaceutical Joint Stock Company. Cai Lay Veterinary Pharmaceutical Joint Stock ...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 104
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MKV

Financial Performance

In 2024, HNX:MKV's revenue was 107.04 billion, a decrease of -3.49% compared to the previous year's 110.91 billion. Earnings were 7.32 billion, an increase of 18.11%.